These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 10215757)

  • 1. Low use of long-term hormone replacement therapy in Denmark.
    Olesen C; Steffensen FH; Sørensen HT; Nielsen GL; Olsen J; Bergman U
    Br J Clin Pharmacol; 1999 Mar; 47(3):323-8. PubMed ID: 10215757
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hormone replacement therapy in Denmark, 1995-2004.
    Løkkegaard E; Lidegaard O; Møller LN; Agger C; Andreasen AH; Jørgensen T
    Acta Obstet Gynecol Scand; 2007; 86(11):1342-51. PubMed ID: 17963062
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Utilization of hormone replacement therapy in Spain: Trends in the period 2000-2014].
    Baladé Martínez L; Montero Corominas D; Macías Saint-Gerons D
    Med Clin (Barc); 2016 Oct; 147(7):287-92. PubMed ID: 27423654
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hormone replacement therapy: patterns of use studied through British general practice computerized records.
    Lawrence M; Jones L; Lancaster T; Daly E; Banks E
    Fam Pract; 1999 Aug; 16(4):335-42. PubMed ID: 10493702
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Analysis of prescriptions associated to hormone replacement therapy in Midi-Pyrénées region].
    Gass-Jégu F; Damase-Michel C; Hurault-Delarue C; Bourrel R; Montastruc JL
    Therapie; 2012; 67(2):121-8. PubMed ID: 22850098
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oestrogen and progestogen hormone replacement therapy for peri-menopausal and post-menopausal women: weight and body fat distribution.
    Norman RJ; Flight IH; Rees MC
    Cochrane Database Syst Rev; 2000; (2):CD001018. PubMed ID: 10796730
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Current use of unopposed estrogen and estrogen plus progestin and the risk of acute myocardial infarction among women with diabetes: the Northern California Kaiser Permanente Diabetes Registry, 1995-1998.
    Ferrara A; Quesenberry CP; Karter AJ; Njoroge CW; Jacobson AS; Selby JV;
    Circulation; 2003 Jan; 107(1):43-8. PubMed ID: 12515741
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use and overuse of sumatriptan. Pharmacoepidemiological studies based on prescription register and interview data.
    Gaist D
    Cephalalgia; 1999 Oct; 19(8):735-61. PubMed ID: 10570730
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An evaluation of the benefits of taking hormone replacement therapy with other prescription drugs.
    Jacobs PA; Hyland ME
    Maturitas; 2003 Dec; 46(4):273-81. PubMed ID: 14625124
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of menopausal hormones in the United States, 1992 through June, 2003.
    Wysowski DK; Governale LA
    Pharmacoepidemiol Drug Saf; 2005 Mar; 14(3):171-6. PubMed ID: 15386701
    [TBL] [Abstract][Full Text] [Related]  

  • 11. National use of postmenopausal hormone therapy: annual trends and response to recent evidence.
    Hersh AL; Stefanick ML; Stafford RS
    JAMA; 2004 Jan; 291(1):47-53. PubMed ID: 14709575
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of hormone replacement therapy on breast cancer risk: estrogen versus estrogen plus progestin.
    Ross RK; Paganini-Hill A; Wan PC; Pike MC
    J Natl Cancer Inst; 2000 Feb; 92(4):328-32. PubMed ID: 10675382
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fracture reducing potential of hormone replacement therapy on a population level.
    Vestergaard P; Rejnmark L; Mosekilde L
    Maturitas; 2006 Jun; 54(3):285-93. PubMed ID: 16413706
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Socioeconomic status and use of postmenopausal hormone replacement therapy among Danish women.
    Olesen AV; Johnsen SP; Mortensen JT; Bøggild H; Olsen J; Sørensen HT
    Acta Obstet Gynecol Scand; 2005 Jul; 84(7):639-44. PubMed ID: 15954872
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dramatic change in prescribing of hormone replacement therapy in The Netherlands after publication of the Million Women Study: a follow-up study.
    Faber A; Bouvy ML; Loskamp L; van de Berg PB; Egberts TC; de Jong-van den Berg LT
    Br J Clin Pharmacol; 2005 Dec; 60(6):641-7. PubMed ID: 16305589
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of hormone replacement therapy of the age-related rise of factor VIIc, and its activity state.
    Wright D; Poller L; Thomson JM; Burrows GE; Hirst CF; Sidebotham A
    Thromb Res; 1997 Mar; 85(6):455-64. PubMed ID: 9101638
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hormone replacement therapy among Danish women aged 45-65 years: prevalence, determinants, and compliance.
    Oddens BJ; Boulet MJ
    Obstet Gynecol; 1997 Aug; 90(2):269-77. PubMed ID: 9241307
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Current estrogen-progestin and estrogen replacement therapy in elderly women: association with carotid atherosclerosis. CHS Collaborative Research Group. Cardiovascular Health Study.
    Jonas HA; Kronmal RA; Psaty BM; Manolio TA; Meilahn EN; Tell GS; Tracy RP; Robbins JA; Anton-Culver H
    Ann Epidemiol; 1996 Jul; 6(4):314-23. PubMed ID: 8876842
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combined estrogen and progestin hormone replacement therapy in relation to risk of breast cancer in middle-aged women.
    Stanford JL; Weiss NS; Voigt LF; Daling JR; Habel LA; Rossing MA
    JAMA; 1995 Jul; 274(2):137-42. PubMed ID: 7596001
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Patient noncompliance with hormone replacement therapy: a nationwide estimate using a large prescription claims database.
    Faulkner DL; Young C; Hutchins D; McCollam JS
    Menopause; 1998; 5(4):226-9. PubMed ID: 9872489
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.